Nur Nicholson is Chief Technical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 56,287 shares of APLS, which is worth approximately $1.62 Million. The most recent transaction as insider was on Mar 13, 2024, when has been sold 11,220 shares (Common Stock) at a price of $57.72 per share, resulting in proceeds of $647,618. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.3K
0% 3M change
5.64% 12M change
Total Value Held $1.62 Million

Nur Nicholson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 13 2024
SELL
Open market or private sale
$647,618 $57.72 p/Share
11,220 Reduced 16.62%
56,287 Common Stock
Jan 29 2024
SELL
Open market or private sale
$53,556 $64.14 p/Share
835 Reduced 1.22%
67,507 Common Stock
Jan 22 2024
SELL
Open market or private sale
$168,545 $65.0 p/Share
2,593 Reduced 3.66%
68,342 Common Stock
Jan 16 2024
SELL
Open market or private sale
$124,066 $66.81 p/Share
1,857 Reduced 2.55%
70,935 Common Stock
Jan 16 2024
BUY
Grant, award, or other acquisition
-
19,508 Added 21.14%
72,792 Common Stock
Sep 18 2023
SELL
Open market or private sale
$899,063 $44.18 p/Share
20,350 Reduced 27.64%
53,284 Common Stock
Sep 18 2023
BUY
Exercise of conversion of derivative security
$289,237 $29.76 p/Share
9,719 Added 11.66%
73,634 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$48,262 $58.5 p/Share
825 Reduced 1.28%
63,503 Common Stock
Feb 21 2023
BUY
Grant, award, or other acquisition
-
9,886 Added 13.32%
64,328 Common Stock
Jan 27 2023
SELL
Payment of exercise price or tax liability
$29,076 $52.77 p/Share
551 Reduced 1.0%
54,442 Common Stock
Jan 20 2023
SELL
Payment of exercise price or tax liability
$105,869 $52.05 p/Share
2,034 Reduced 3.57%
54,993 Common Stock
Jan 12 2023
BUY
Grant, award, or other acquisition
-
22,580 Added 28.36%
57,027 Common Stock
Apr 25 2022
SELL
Other acquisition or disposition
-
1,875 Reduced 5.27%
33,680 Common Stock
Jan 28 2022
SELL
Payment of exercise price or tax liability
$25,084 $38.59 p/Share
650 Reduced 1.8%
35,555 Common Stock
Jan 21 2022
BUY
Grant, award, or other acquisition
-
26,051 Added 41.84%
36,205 Common Stock
Jan 28 2021
BUY
Grant, award, or other acquisition
-
9,375 Added 50.0%
9,375 Common Stock
NN

Nur Nicholson

Chief Technical Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS